Image default
Business

Speciality chemicals producer Lygos gets green light for three grants.

“The current petrochemical processes used to manufacture speciality chemicals like malonic, glycolic and glyceric acids, are not only expensive but they also have significant health, safety and environmental concerns.”

Lygos, a US biotech producer of speciality chemicals, has announced that it has won three innovation research grants totalling $750,000. This non-equity funding will help to support its advanced research and development.

These funds have been awarded through separate grants from the US Department of Energy (DOE), United States Department of Agriculture (USDA) and the National Science Foundation (NSF).

“These three grants are a vital tool for driving innovation and exploring new approaches to outdated or challenging manufacturing practices,” said Eric Steen, PhD, Co-founder and CEO of Lygos (@LygosBiotech).

He added: “Lygos is proud to partner with these agencies and their tremendous teams of scientists to apply our bio-based speciality chemicals in ways that revive innovation across large-scale industries from consumer electronics to health and nutrition to high-performance plastics and materials.”

The following three Small Business Innovation Research (SBIR) Grants will support the development of new approaches for the sustainable production of high-value, specialty organic acids used to manufacture a variety of high-performance polymers.

National Science Foundation Phase IIB SBIR Grant ($500k) aims to develop new technologies to fix CO2 during microbial biochemical production, providing new ways to capture and valorise this abundant greenhouse gas.

DOE phase SBIR Grant ($150k) concentrates on solving purity and cost issues related to the incumbent processes used in glycolic acid manufacturing.

USDA Phase I SBIR Grant ($100k) focuses on biological technologies to produce glyceric acid, an enabling chemical for manufacturing new polycarbonates.

“The current petrochemical processes used to manufacture speciality chemicals like malonic, glycolic and glyceric acids, are not only expensive but they also have significant health, safety and environmental concerns,” said Jeffrey Dietrich, PhD, Co-founder and Chief Technology Officer of Lygos.

He added: “At Lygos, we are focusing our effort on providing sustainable, cost-competitive biological solutions that address some of these fundamental inefficiencies in current petrochemical manufacturing processes.”

According to Lygos, its proprietary platform is based on a high-throughput combination of computational modelilng, unique microbe engineering and screening, and machine learning to identify and develop new bio-routes to chemicals.

Lygos uses modern biotechnology to deliver the benefits of petroleum-based and other industrial chemical technology without environmental toxicity at competitive prices. Lygos also develops unique bio-based routes to chemical functionalities to expand the performance window in diverse materials systems.


You may also be interested in reading…

Read: 5 minutes with… Andreas Kohl, Head of Research & Development Biotechnology at Clariant and member of the European Chemical Industry Council.

ReadHow are researchers using silk to create large scale biotechnology solutions?

Read: Industry giants Gevo & Clariant announce revolutionary new biotechnology project

Related posts

Banks are doing “too little” to communicate their sustainable investment products; report.

Luke Upton

5 Minutes with… Bruno Rudnik, Managing Director at SusTech Consult.

Dave Songer

5 Minutes With… Dr Minshad A Ansari from Bionema.

Liz Gyekye

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More